総合的なマルチオミクスプロファイリングは,デクストラン硫酸ナトリウム誘発性大腸炎に対するギペノシドの保護機能を明らかにした
Yuan Yang1, Xinyuan Li1, Fan Huang1
1Department of Gastroenterology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
Scientific reports
|August 28, 2025
まとめ
ジペノシドは,幹細胞遺伝子と代謝経路を調節することによって,大腸炎を効果的に治療します. この研究は,ギペノシドが潰瘍性大腸炎 (UC) の症状を緩和し,マウスモデルで粘膜の修復を促進することを示しています.
科学分野:
- 胃腸内科
- 薬理学について
- 分子生物学
背景:
- 潰瘍性大腸炎 (UC) は慢性炎症性腸疾患である.
- UCの現在の治療には限界があり,新しい治療戦略が必要である.
- ジペノシドは,潜在的抗炎症性を持つ天然化合物です.
研究 の 目的:
- 大腸炎に対するジペノシドの治療効果を調査する
- 潰瘍性大腸炎 (UC) の治療におけるギペノシドの基礎的分子機構を,マルチオミクス分析を用いて解明する.
主な方法:
- デクストラン硫酸ナトリウム (DSS) を用いたUCマウスモデルを確立した.
- グイペノシドをUCマウスのサブグループに投与した.
- 組織学,分子学,トランスクリプトーム学,代謝学分析を行った.
- 重要なタンパク質を検出するために免疫ヒストケミストリーを使用しました.
主要な成果:
- ジペノシド治療は,臨床症状を大幅に緩和し,大腸の縮小を軽減し,DSS誘発UCマウスにおける疾患活動指数 (DAI) を低下させた.
- トランスクリプトーム解析により,腸の幹細胞遺伝子Ascl2とLgr5の差異的発現が確認された.
- メタボロミクスは,トリカルボキシル酸サイクル (TCA) とアミノ酸代謝 (AM) の経路の変化を示した.
結論:
- ジペノシドは,おそらく幹細胞活動を調節することによって,大腸炎の治療の可能性を示しています.
- TCAやアミノ酸の代謝などの代謝経路を調節する仕組みです.
- ギペノシドは損傷した結腸粘膜の修復を促進し,UCの治療に有望な道を提供します.
関連する概念動画
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.6K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.6K
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
1.1K
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
1.1K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
2.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.3K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.7K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.7K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
1.0K
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
1.0K
Peptic Ulcer Disease IV: Management
807
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
807


